Understanding the role of HIV load in determining weight change in the era of highly active antiretroviral therapy

Clinical Infectious Diseases

Volumn 40, Issue 1, 2005, Pages 167-173

  Mwamburi, D Mkaya ^a   Wilson, Ira B ^a   Jacobson, Denise L ^b   Spiegelman, Donna ^c   Gorbach, Sherwood L ^a,b   Knox, Tamsin A ^b   Wanke, Christine A ^a,b  

^a TUFTS MEDICAL CENTER   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; ARTICLE; BODY WEIGHT; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG DOSE REGIMEN; ENERGY EXPENDITURE; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROSPECTIVE STUDY; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; VIRUS LOAD; WEIGHT REDUCTION;

ADULT; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BODY WEIGHT; CD4 LYMPHOCYTE COUNT; FEMALE; HIV; HIV INFECTIONS; HUMANS; RNA, VIRAL; VIRAL LOAD;

EID: 11144221174     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/426591     Document Type: Article

References (28)

1. Wanke CA, Silva M, Knox TA, et al. Weight loss and wasting remain common complications in individuals infected with human immunodeficiency virus in the era of highly active antiretroviral therapy. Clin Infect Dis 2000; 31:803-5.
2. Kotler DP, Tierney AR, Wang J, Pierson RN Jr. Magnitude of body-cell-mass depletion and the timing of death from wasting in AIDS. Am J Clin Nutr 1989; 50:444-7.
3. Melchior JC, Niyongabo T, Henzel D, et al. Malnutrition and wasting, immunodepression, and chronic inflammation as independent predictors of survival in HIV-infected patients. Nutrition 1999; 15:865-9.
4. Palenicek JP, Graham NM, He YD, et al. Weight loss prior to clinical AIDS as a predictor of survival. Multicenter AIDS Cohort Study Investigators. J Acquir Immune Defic Syndr Hum Retrovirol 1995; 10:366-73.
5. Wheeler DA, Gibert CL, Launer CA, et al. Weight loss as a predictor of survival and disease progression in HIV infection. Terry Beirn Community Programs for Clinical Research on AIDS. J Acquir Immune Defic Syndr Hum Retrovirol 1998; 18:80-5.
6. Tang AM, Forrester J, Spiegelman D, et al. Weight loss and survival in HIV-positive patients in the era of highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2002; 31:230-6.
7. Nemechek PM, Polsky B, Gottlieb MS. Treatment guidelines for HIV-associated wasting. Mayo Clin Proc 2000; 75:386-94.
8. Wanke CA, Silva M, Ganda A, et al. Role of acquired immune deficiency syndrome-defining conditions in human immunodeficiency virus-associated wasting. Clin Infect Dis 2003; 37(Suppl 2):S81-4.
9. Jacobson DL, Bica I, Knox TA, et al. Difficulty swallowing and lack of receipt of highly active antiretroviral therapy predict acute weight loss in human immunodeficiency virus disease. Clin Infect Dis 2003; 37:1349-56.
10. Woods MN, Spiegelman D, Knox TA, et al. Nutrient intake and body weight in a large HIV cohort that includes women and minorities. J Am Diet Assoc 2002; 102:203-11.
11. Shevitz AH, Knox TA, Spiegelman D, et al. Elevated resting energy expenditure among HIV-seropositive persons receiving highly active antiretroviral therapy. AIDS 1999; 13:1351-7.
12. Forrester JE, Spiegelman D, Tchetgen E, Knox TA, Gorbach SL. Weight loss and body-composition changes in men and women infected with HIV. Am J Clin Nutr 2002; 76:1428-34.
13. Suva M, Skolnik PR, Gorbach SL, et al. The effect of protease inhibitors on weight and body composition in HIV-infected patients. AIDS 1998; 12:1645-51.
14. Wilson IB, Roubenoff R, Knox TA, Spiegelman D, Gorbach SL. Relation of lean body mass to health-related quality of life in persons with HIV. J Acquir Immune Defic Syndr 2000; 24:137-46.
15. Woods MN, Tang AM, Forrester J, et al. Effect of dietary intake and protease inhibitors on serum vitamin B12 levels in a cohort of human immunodeficiency virus-positive patients. Clin Infect Dis 2003; 37(Suppl 2):S124-31.
16. Knox TA, Spiegelman D, Skinner SC, Gorbach S, Diarrhea and abnormalities of gastrointestinal function in a cohort of men and women with HIV infection. Am J Gastroenterol 2000; 95:3482-9.
17. Forrester JE, Woods MN, Knox TA, et al. Body composition and dietary intake in relation to drug abuse in a cohort of HIV-positive persons. I Acquir Immune Defic Syndr 2000; 25(Suppl 1):S43-8.
18. Batterham MJ, Garsia R, Greenop P. Prevalence and predictors of HIV-associated weight loss in the era of highly active antiretroviral therapy. Int J STD AIDS 2002; 13:744-7.
19. Lyles RH, Tang AM, Smit E, et al. Virologic, immunologic, andimmune activation markers as predictors of HIV-associated weight loss prior to AIDS. Multicenter AIDS Cohort Study. J Acquir Immune Defic Syndr 1999; 22:386-94.
20. Mwamburi DM, Gerrior J, Wilson IB, et al. Combination megestrol acetate, oxandrolone, and dietary advice restores weight in human immunodeficiency virus. Nutr Clin Pract 2004; 18:395-402.
21. Teixeira A, Leu JC, Honderlick P, Trylesinski A, Zucman D. Variation in body weight and plasma viral load in HIV patients treated with tritherapy including a protease inhibitor [abstract]. Nutrition 1997; 13:269.
22. Zucman D, Teixeira A, Olivieri MP, Honderlick P, Trilesinski A, Harzic M. Correlates between body composition, caloric intake and plasma viral load in HIV infected patients [abstract]. Nutrition 1997; 13:292.
23. Shevitz AH. Management trends: resting energy expenditure in the HAART era. AIDS Reader 2000; 10:539-44, 557-8.
24. + lymphocyte counts and the risk of progression to AIDS. Veterans Affairs Cooperative Study Group on AIDS. N Engl J Med 1996; 334:426-31.
25. + lymphocytes as prognostic markers of HIV-1 infection. Ann Intern Med 1997; 126:946-54.
26. Grinspoon S, Corcoran C, Askari H, et al. Effects of androgen administration in men with the AIDS wasting syndrome: a randomized, double-blind, placebo-controlled trial. Ann Intern Med 1998; 129:18-26.
27. Sheehan LA, Macallan DC. Determinants of energy intake and energy expenditure in HIV and AIDS. Nutrition 2000; 16:101-6.
28. Suttmann U, Ockenga J, Hoogestraat L, et al. Resting energy expenditure and weight loss in human immunodeficiency virus-infected patients. Metabolism 1993; 42:1173-9.